News specifically tailored to medical oncologists
Expert Review: COSA Public Forum 2017
A small but enthusiastic group of people gathered on the eve of the COSA ASM…
Browsing: Medical Oncology
Nano-targeting treatment for prostate cancer
Metastatic or castrate-resistant prostate cancer can spread to the bone in certain patients. While several…
Nonalcoholic fatty liver disease increases risk of liver, colorectal, and breast cancers
Nonalcoholic fatty liver disease (NAFLD) is one of the more common chronic liver diseases worldwide.…
Long Read: What causes breast cancer in women? What we know, don’t know and suspect
Andrew Redfern, University of Western Australia and Rik Thompson, Queensland University of Technology Breast cancer…
COSA 2017: How do we improve cancer care?
Professor Dorothy Keefe, from the University of Adelaide, presented at the Clinical Oncology Society of…
COSA 2017: Do new drugs require new models of funding?
Attendees at the Clinical Oncology Society of Australia Annual Scientific Meeting discussed whether new immunotherapy…
COSA 2017: New eHealth technology empowers patients and helps improve care
Experts attending the COSA conference discussed how an Australian first integrated eHealth solution is empowering…
COSA 2017: New research leads way for fast tracking lung cancer diagnosis
A new initiative is successfully encouraging those at higher risk of lung cancer to act…
COSA 2017: Financial pressure toxic for those with cancer
Experts presenting at the COSA conference discussed the financial pressures that people diagnosed with cancer…
Relearning Supportive Care with Immunotherapies
By Professor Ian Olver AM, for oncologynews.com.au. There has been a rapid paradigm shift in anticancer treatment…